Effects of Resveratrol on Hepatitis B Virus Replication: In vitro and in vivo Experiments

被引:10
|
作者
Pan, Peipei [1 ]
Li, Jiaohui [2 ]
Lin, Wei [3 ]
Long, Guangyan [1 ]
机构
[1] First Peoples Hosp Wenling, Dept Infect Dis, Wenling, Peoples R China
[2] Taizhou Canc Hosp, Dept Internal Med 1, Taizhou, Peoples R China
[3] First Peoples Hosp Wenling, Dept Resp Med, Wenling, Peoples R China
关键词
Hepatitis B virus; Resveratrol; miR-155; Autophagy; Virus replication; ACTIVATION;
D O I
10.1159/000525807
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: Hepatitis B virus (HBV) infection is a disease with high incidence and lack of effective treatment. In this study, we further explored the mechanism of resveratrol (RVT) in the inhibition of HBV replication. The effects of RVT on HBV replication were verified using in vitro and in vivo experiments. Methods: HepG2 and HepG2.2.15 cell lines were cultured in vitro, and different concentrations of RVT were used to determine its effect on the proliferation of the two cell lines. Autophagy agonists and inhibitors were given, and whether RVT exerts its effect on the proliferation of HepG2 and HepG2.2.15 cells through autophagy was determined. Reverse transcription-quantitative polymerase chain reaction and Western blot were used to detect changes in autophagy-related factors LC3-II, LC3-I, Beclin 1, and p62. Through transfection of pmiR-155, shmiR-155, and the corresponding control group, the relevant mechanism of RVT in inhibiting the proliferation of HepG2 and HepG2.2.15 cells was analyzed. RVT inhibited the toxicity for HepG2.2.15 cells and reduced HBV replication in vitro (p < 0.05). This effect of RVT was enhanced by rapamycin (RAPA; autophagy activator; p < 0.05) but was partially reversed by 3-MA (autophagy inhibitor; p < 0.05). In addition, our results showed that miR-155 expression was higher in HepG2.2.15 cells than in HepG cells (p < 0.05). miR-155 expression in the RVT treatment group was significantly reduced (p < 0.05). We designed an miR-155 overexpression plasmid, low miR-155 expression plasmid, and the corresponding negative control for transfection and found that transfection of pmiR-155 can partially reverse the effect of RVT (p < 0.05), while transfection with shmiR-155 can enhance the effect of RVT (p < 0.05). Discussion: RVT inhibits miR-155, activates autophagy, inhibits the toxicity for HepG2.2.15 cells, and reduces HBV replication, providing a new research direction for the treatment of HBV infection.
引用
收藏
页码:206 / 214
页数:9
相关论文
共 50 条
  • [1] The replication fitness of hepatitis B virus is regulated by the enhancer I in vitro and in vivo
    Bock, TC
    Malek, NP
    Tillmann, HL
    Manns, MP
    Trautwein, C
    HEPATOLOGY, 1999, 30 (04) : 446A - 446A
  • [2] Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo
    Zhou, Zhe
    Zhang, Yi
    Ding, Xiao-Ran
    Chen, Su-Hong
    Yang, Jing
    Wang, Xue-Jun
    Jia, Gao-Long
    Chen, Hong-Shan
    Bo, Xiao-Chen
    Wang, Sheng-Qi
    ANTIVIRAL RESEARCH, 2007, 74 (01) : 59 - 64
  • [3] Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo
    Cheng, Sheng-Tao
    Tang, Hua
    Ren, Ji-Hua
    Chen, Xiang
    Huang, Ai-Long
    Chen, Juan
    PLOS ONE, 2017, 12 (06):
  • [4] Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo
    Keasler, Victor V.
    Hodgson, Amanda J.
    Madden, Charles R.
    Slagle, Betty L.
    JOURNAL OF VIROLOGY, 2007, 81 (06) : 2656 - 2662
  • [5] Inhibition of Hepatitis B virus replication by Phospholipid scramblase 1 in vitro and in vivo
    Yang, Jing
    Zhu, Xiangqian
    Liu, Juan
    Ding, Xiaoran
    Han, Mingming
    Hu, Wei
    Wang, Xuejun
    Zhou, Zhe
    Wang, Shengqi
    ANTIVIRAL RESEARCH, 2012, 94 (01) : 9 - 17
  • [6] In vitro and in vivo replication of a chemically synthesized consensus genome of hepatitis B Virus genotype B
    Zhang, Zhenhua
    Xia, Jianbo
    Sun, Binghu
    Dai, Yu
    Li, Xu
    Schlaak, Joerg F.
    Lu, Mengji
    JOURNAL OF VIROLOGICAL METHODS, 2015, 213 : 57 - 64
  • [7] Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo
    Yan-Chang Lei
    World Journal of Gastroenterology, 2006, (28) : 4492 - 4497
  • [8] Inhibition of Hepatitis B Virus Replication by a Novel GalNAc-siRNA In Vivo and In Vitro
    Zhang, Zhipeng
    Ma, Yanqin
    He, Yan
    Wang, Dong
    Yue, Kun
    Zhang, Xiaomei
    Song, Huaien
    ACS OMEGA, 2025, 10 (01): : 484 - 497
  • [9] Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo
    Yan-Chang Lei
    You-Hua Hao
    Zheng-Mao Zhang
    Yong-Jun Tian
    Bao-Ju Wang
    Yan Yang
    Xi-Ping Zhao
    Meng-Ji Lu
    Fei-Li Gong
    Dong-Liang Yang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (28) : 4492 - 4497
  • [10] Difference of viral replication and protein production by hepatitis B virus genotypes using replication model in vitro and in vivo
    Sugiyama, M
    Tanaka, Y
    Kato, T
    Ito, K
    Orito, E
    Chayama, K
    Yoshizawa, H
    Mizokami, M
    HEPATOLOGY, 2005, 42 (04) : 717A - 717A